JP2025501913A5 - - Google Patents
Info
- Publication number
- JP2025501913A5 JP2025501913A5 JP2024538390A JP2024538390A JP2025501913A5 JP 2025501913 A5 JP2025501913 A5 JP 2025501913A5 JP 2024538390 A JP2024538390 A JP 2024538390A JP 2024538390 A JP2024538390 A JP 2024538390A JP 2025501913 A5 JP2025501913 A5 JP 2025501913A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2022-0001647 | 2022-01-05 | ||
| KR1020220001647A KR20230105972A (ko) | 2022-01-05 | 2022-01-05 | 혈관신생 억제제가 결합된 항-C3b 항체 또는 항-C5 항체 및 이의 용도 |
| PCT/KR2022/021371 WO2023132547A1 (ko) | 2022-01-05 | 2022-12-27 | 혈관신생 억제제가 결합된 항-c3b 항체 또는 항-c5 항체 및 이의 용도 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025501913A JP2025501913A (ja) | 2025-01-24 |
| JPWO2023132547A5 JPWO2023132547A5 (https=) | 2025-12-02 |
| JP2025501913A5 true JP2025501913A5 (https=) | 2025-12-02 |
Family
ID=87073766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024538390A Pending JP2025501913A (ja) | 2022-01-05 | 2022-12-27 | 血管新生阻害剤結合抗Ｃ３ｂ抗体又は抗Ｃ５抗体及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250074974A1 (https=) |
| EP (1) | EP4461745A4 (https=) |
| JP (1) | JP2025501913A (https=) |
| KR (1) | KR20230105972A (https=) |
| CN (1) | CN118510799A (https=) |
| AU (1) | AU2022430428A1 (https=) |
| WO (1) | WO2023132547A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3189030A1 (en) * | 2020-07-07 | 2022-01-13 | Kanaph Therapeutics Inc. | Fusion protein including complement pathway inhibitor and angiogenesis inhibitor and use thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6074642A (en) | 1994-05-02 | 2000-06-13 | Alexion Pharmaceuticals, Inc. | Use of antibodies specific to human complement component C5 for the treatment of glomerulonephritis |
| JP4897690B2 (ja) | 2004-10-12 | 2012-03-14 | ジェネンテック， インコーポレイテッド | 補体関連障害の予防および処置のためのＣＲＩｇポリペプチド |
| PL3167888T3 (pl) * | 2006-03-15 | 2024-08-26 | Alexion Pharmaceuticals, Inc. | Leczenie pacjentów z napadową nocną hemoglobinurią za pomocą inhibitora dopełniacza |
| US10259860B2 (en) * | 2007-02-27 | 2019-04-16 | Aprogen Inc. | Fusion proteins binding to VEGF and angiopoietin |
| BRPI0812767A2 (pt) * | 2007-06-07 | 2014-12-02 | Genentech Inc | Anticorpos para c3b e métodos para prevenção e tratamento de distúrbios associados ao complemento |
| US8268314B2 (en) | 2008-10-08 | 2012-09-18 | Hoffmann-La Roche Inc. | Bispecific anti-VEGF/anti-ANG-2 antibodies |
| US20100291106A1 (en) | 2009-05-06 | 2010-11-18 | Novartis Ag | Compositions and methods for antibodies targeting complement protein c3b |
| US9527925B2 (en) | 2011-04-01 | 2016-12-27 | Boehringer Ingelheim International Gmbh | Bispecific binding molecules binding to VEGF and ANG2 |
| BR112014013205A2 (pt) * | 2011-12-01 | 2020-10-27 | Protevobio, Inc. | proteína de fusão, seu uso e seu método de produção, composição farmacêutica, ácido nucleico, e kit |
| CA3056248A1 (en) * | 2017-03-22 | 2018-09-27 | Genentech, Inc. | Optimized antibody compositions for treatment of ocular disorders |
| WO2019112958A1 (en) | 2017-12-05 | 2019-06-13 | Abbvie Biotherapeutics Inc. | Abt-165 in combination with folinic acid, 5-fluorouracil, and irinotecan for the treatment of cancers |
| MA51147A (fr) | 2017-12-13 | 2021-03-24 | Regeneron Pharma | Associations d'anticorps anti-c5 et utilisations associées |
| US20200115443A1 (en) * | 2018-10-12 | 2020-04-16 | Trican Biotechnology Co., Ltd | Bi-functional fusion proteins and uses thereof |
| EP4308591A4 (en) * | 2021-03-18 | 2025-04-02 | Affilogic | POLYPEPTIDES FOR COMPLEMENT INHIBITION |
-
2022
- 2022-01-05 KR KR1020220001647A patent/KR20230105972A/ko active Pending
- 2022-12-27 US US18/726,333 patent/US20250074974A1/en active Pending
- 2022-12-27 JP JP2024538390A patent/JP2025501913A/ja active Pending
- 2022-12-27 AU AU2022430428A patent/AU2022430428A1/en active Pending
- 2022-12-27 CN CN202280087754.8A patent/CN118510799A/zh active Pending
- 2022-12-27 EP EP22919084.8A patent/EP4461745A4/en active Pending
- 2022-12-27 WO PCT/KR2022/021371 patent/WO2023132547A1/ko not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2025003539A1 (es) | Uso de información de asistencia de conmutación de célula para búsqueda de ssb durante conmutación de satélite | |
| JP2025501913A5 (https=) | ||
| BR102022025291A2 (https=) | ||
| BR102023014872A2 (https=) | ||
| BR102023012440A2 (https=) | ||
| BR102023010976A2 (https=) | ||
| BR102023009641A2 (https=) | ||
| BR102023008688A2 (https=) | ||
| BR102023005164A2 (https=) | ||
| BR102023001877A2 (https=) | ||
| BR102023000289A2 (https=) | ||
| BR102022026909A2 (https=) | ||
| BR202022000931U2 (https=) | ||
| BY13174U (https=) | ||
| BY13165U (https=) | ||
| CN307044774S (https=) | ||
| BY23966C1 (https=) | ||
| BY23965C1 (https=) | ||
| CN307045158S (https=) | ||
| BY23963C1 (https=) | ||
| CN307045815S (https=) | ||
| CN307045979S (https=) | ||
| BY13176U (https=) | ||
| BY13175U (https=) | ||
| BY13141U (https=) |